瑞科生物－Ｂ：2022年報.pdf

1、 (a joint stock company incorporated in the Peoples Republic of China with limited liability)（於中華人民共和國註冊成立的股份有限公司）Stock Code 股份代號:2179江蘇瑞科生物技術股份有限公司Jiangsu Recbio Technology Co.,Ltd.ANNUAL REPORT2022年 報2Corporate Information公司資料5Chairmans Statement主席致辭7Financial Highlights財務摘要8Management Discussion

2、and Analysis管理層討論與分析38Biographies of our Directors,Supervisors and Senior Management董事、監事及高級管理層履歷56Directors Report董事會報告94Corporate Governance Report企業管治報告121Independent Auditors Report獨立核數師報告130Consolidated Statement of Profit or Loss and Other Comprehensive Income綜合損益及其他全面收益表131Consolidated Statem

3、ent of Financial Position綜合財務狀況表133Consolidated Statement of Changes in Equity綜合權益變動表135Consolidated Statement of Cash Flows綜合現金流量表137Notes to Financial Statements財務報表附註233Definitions and Glossary of Technical Terms釋義及技術詞彙Contents目錄2Jiangsu Recbio Technology Co.,Ltd.江蘇瑞科生物技術股份有限公司Corporate Informati

4、on公司資料DIRECTORSExecutive DirectorsDr.LIU Yong(Chairman of the Board and General Manager)Dr.CHEN JianpingMr.LI BuNon-Executive Directors1Dr.HONG KunxueDr.ZHOU HongbinIndependent Non-Executive DirectorsMr.LIANG GuodongDr.XIA LijunProfessor GAO FengProfessor YUEN Ming FaiSUPERVISORSMs.QIAO Weiwei2(Chai

5、rwoman)Mr.WANG Feizhou3Ms.QIAN RantingMs.LIU Ping4JOINT COMPANY SECRETARIESMs.CHEN QingqingMs.HO Yin Kwan5AUTHORISED REPRESENTATIVESDr.LIU YongMr.LI Bu董事執行董事劉勇博士（董事會主席兼總經理）陳健平博士李布先生非執行董事1洪坤學博士周宏斌博士獨立非執行董事梁國棟先生夏立軍博士GAO Feng教授袁銘輝教授監事喬偉偉女士2（主席）王飛舟先生3錢然婷女士劉平女士4聯席公司秘書陳青青女士何燕群女士5授權代表劉勇博士李布先生1 Mr.ZHAO Hui

6、and Dr.DU Wei resigned as non-executive Directors and members of the Remuneration and Appraisal Committee on March 20,2023.Dr.FENG Tao resigned as a non-executive Director and a member of the Nomination Committee on April 3,2023.2 Ms.QIAO Weiwei was appointed as the chairwoman of the Supervisory Boa